Percutaneous Treatment of Partial Anomalous Pulmonary Venous Drainage
Partial Anomalous Pulmonary Venous Connection
About this trial
This is an interventional supportive care trial for Partial Anomalous Pulmonary Venous Connection focused on measuring congenital heart disease
Eligibility Criteria
Inclusion Criteria: Haemodynamically & Functionally significant PAPVD (all of the following) Right heart dilated on trans thoracic echo cardiac MRI Qp:Qs ≥ 1.3:1, and right ventricular to left ventricular volume (RV:LV) ratio ≥ 1.5:1 Maximal oxygen consumption (VO2 max) on cardiopulmonary exercise testing < 85% predicted Normal pulmonary artery pressure No contra-indication to pulmonary artery intervention procedure under general anaesthetic Able to give informed consent Exclusion Criteria: Contra-indication to cardiac MRI Not able to give informed consent Contra-indication to pulmonary artery intervention under general anaesthetic
Sites / Locations
- Leeds Teaching Hospitals NHS Trust
Arms of the Study
Arm 1
Other
main